| Line Item | 2023-08-31 | Y/Y |
|---|---|---|
| Revenue | $6.0M | -15.2% |
| Cost of Revenue | $5.0M | -12.1% |
| Gross Profit | $1.0M | -27.9% |
| R&D Expense | $1.4M | -8.8% |
| SG&A Expense | $3.1M | -7.6% |
| Operating Income | -$3.4M | -6.4% |
| Pre-tax Income | -$2.7M | +1.3% |
| Net Income | -$2.7M | +2.0% |
| EPS (Basic) | -$0.55 |
| Line Item | 2023-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.6M | -39.8% |
| Accounts Receivable | $793K | -9.9% |
| Inventory | $4.0M | +6.3% |
| Current Assets | $7.6M | -16.9% |
| Total Assets | $13.5M | -16.2% |
| Current Liabilities | $9.7M | +4.8% |
| Long-term Debt | $6.4M | -8.1% |
| Line Item | 2023-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$984K | +34.7% |
| Capital Expenditures | $200K | -28.6% |
| Investing Cash Flow | -$321K | -184.1% |
| Financing Cash Flow | -$456K | -193.1% |
| Free Cash Flow | -$1.2M | +33.8% |
| +9.8% |
| EPS (Diluted) | -$0.55 | +9.8% |
| Total Liabilities |
| $12.3M |
| -2.3% |
| Stockholders' Equity | $1.2M | -66.7% |